Situation Report

REUTERS                                                              Dec. 24, 2014

ACCRA—Medical detective work will be the next big phase in the fight against Ebola when the United Nations deploys hundreds of health workers to identify chains of infection as the virus passes from person to person, top U.N. health workers said.
Health workers bury the body of a suspected Ebola victim at a cemetery in Freetown, Dec. 21, 2014.

The health teams will travel to each district and region of Guinea, Sierra Leone and Liberia, the three countries at the center of the epidemic, to trace who each infected person has potentially contacted.

The effort will run in parallel with measures to minimize the spread of infection, such as treating all Ebola patients in specialized centers and burying all victims safely.

But Phase Two of the plan is to contain the virus by understanding its lines of transmission, said World Health Organization Director-General Margaret Chan.

Read complete story

THE WASHINGTON POST  by Lena H. Sun and Joel Achenbach       Dec. 24, 2014

One scientist may have been exposed to the Ebola virus and as many as a dozen others are being assessed for potential exposure at a lab of the Centers for Disease Control and Prevention in Atlanta, agency officials said Wednesday.

Experiments with deadly viruses such as Ebola have to be performed in biosafety level or BSL-4 laboratories, for the highest level on containment. (Tim Brakemeier/AFP/Getty Images)

The potential exposure took place Monday when scientists conducting research on the virus at a high-security lab mistakenly put a sample containing the potentially infectious virus in a place where it was transferred for processing to another CDC lab, also in Atlanta on the CDC campus.

The technician has no symptoms of illness and is being monitored for 21 days. Agency spokeswoman Barbara Reynolds said others who entered the lab have been contacted and will be assessed for possible exposure by CDC clinicians. She said the number of exposures could be much less than a dozen.

REUTERS    by Emma Farge                                            Dec. 23, 2014

HASTINGS, Sierra Leone-- When Dr Sekou Kanneh goes to work at his Sierra Leonean Ebola clinic, he will probably be in the "red zone" for many hours, ignoring by necessity strict limits that govern foreign colleagues fighting the epidemic.

Doctor Sekou Kanneh speaks during an interview with Reuters TV in the Hastings ebola treatment centre at a neighbourhood in Freetown, December 21, 2014. Credit: Reuters/Baz Ratner 

Conditions at Kanneh's treatment center, the only Ebola unit in the country run by local staff, contrast to the purpose-built facilities where foreign volunteers who have flocked to Sierra Leone, Guinea and Liberia work.

Kanneh has received no official training to treat the virus that has killed over 7,000 people in West Africa. Still, he works up to four hour shifts in the stifling heat of the red zone, a ward where healthcare workers have direct contact with the highly contagious Ebola patients.

BBC     By Smitha Mundasad                                Dec. 22, 2014
The first-ever trial of an Ebola vaccine in Africa shows promising initial results, according to a report in the Lancet medical journal.

Scientists say it is a crucial step as other vaccines have shown lower levels of protection in African populations.

Tests involving Ugandan and American volunteers reveal the vaccine is so far safe and generates an immune response in both populations.

It provides reassurance for other trials currently underway, they say.

No proven vaccine exists to prevent people from getting the disease, though several trials are underway.

Researchers from the National Institutes of Health tested this experimental vaccine on healthy adults in Uganda, having first trialled it in the United States.

Dr Julie Ledgerwood, the lead researcher, said: "This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population.

Read complete story

http://www.bbc.com/news/health-30577776